Canaccord Genuity Group Has Lowered Expectations for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) had its price target decreased by analysts at Canaccord Genuity Group from $9.50 to $7.00 in a report released on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Canaccord Genuity Group's price objective would suggest a potential upside of 26.13% from the stock's previous close.

Separately, Oppenheimer reduced their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating for the company in a report on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $10.00.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX traded down $0.14 during mid-day trading on Friday, hitting $5.55. 324,519 shares of the company were exchanged, compared to its average volume of 247,720. Bioceres Crop Solutions has a 1-year low of $5.50 and a 1-year high of $14.05. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The stock has a 50 day simple moving average of $6.59 and a 200-day simple moving average of $7.74. The firm has a market cap of $348.04 million, a price-to-earnings ratio of 277.64 and a beta of 0.57.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. During the same period last year, the business posted ($0.07) EPS. On average, sell-side analysts forecast that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Fourth Sail Capital LP increased its position in Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock worth $22,490,000 after purchasing an additional 527,859 shares in the last quarter. JPMorgan Chase & Co. increased its position in Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after purchasing an additional 29,693 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after purchasing an additional 5,341 shares in the last quarter. Ping Capital Management Inc. increased its position in Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock worth $268,000 after purchasing an additional 3,000 shares in the last quarter. Finally, Stifel Financial Corp increased its position in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock worth $321,000 after purchasing an additional 10,224 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.